Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION ‐China study
Authors' conclusion
PLwO and HCPs living in mainland China have different attitudes towards WL treatments, particularly regarding treatment effectiveness and weight regain after WL surgery.
Study context
- Population
- People living with obesity and healthcare professionals in mainland China, August to November 2022completed the survey
- Participants
- 7,000 vs 1,000
- Comparison
- People living with obesity (PLwO) vs healthcare professionals (HCPs)
- PLwOn = 7,000
- HCPsn = 1,000reference
- Primary endpoint
- Attitudes towards prescription of WL medications and WL surgery
Methodological detailsdescriptive, survey-based
- Descriptive
- Survey-based
Primary result
As reported in the abstract
Concern about safety of long-term use of WL medications
Further findings
Concern about safety of WL surgery
Thought WL medications more effective than other treatments
Considered surgery more effective than other options
Concern about weight regain after WL surgery
Society and healthcare system slightly or completely meeting needs
Slightly
Completely
Most important factor for improving weight loss (WL) outcomes
- PLwO and HCPs agreed: increasing awareness that obesity is a chronic disease requiring long-term management
Original publication
Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION ‐China study. Diabetes Obes Metab. Published 15 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →